Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Vaccinia necrosum complicating immunoblastic sarcoma

S B Turkel, G D Overturf

|July 1, 1977

Summary

This case highlights the risks of live viral vaccines in immunocompromised patients. Persistent viral infection may indicate underlying, undetected disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Prevention of hepatitis B in adolescents.

Pediatrics·2001

Same author

Infection with Sin Nombre hantavirus: clinical presentation and outcome in children and adolescents.

Pediatrics·2001

Same author

Possible serotonin syndrome in association with 5-HT(3) antagonist agents.

Psychosomatics·2001

Same author

Case series: neuropsychiatric symptoms with pediatric systemic lupus erythematosus.

Journal of the American Academy of Child and Adolescent Psychiatry·2001

Same author

American Academy of Pediatrics. Committee on Infectious Diseases. Technical report: prevention of pneumococcal infections, including the use of pneumococcal conjugate and polysaccharide vaccines and antibiotic prophylaxis.

Pediatrics·2000

Same author

Sin nombre hantavirus disease in a ten-year-old boy and his mother.

The Pediatric infectious disease journal·2000

Area of Science:

Oncology
Virology
Immunology

Background:

A 59-year-old male patient with a history of immunoblastic lymphadenopathy is presented.
The condition progressed over three years to immunoblastic sarcoma.

Observation:

The patient developed vaccinia necrosum, a severe complication requiring extensive treatment.
Treatment involved Marboran and vaccinia-immune globulin.
Viral persistence was confirmed post-mortem via viral culture and ultrastructural analysis.

Findings:

The case demonstrates the potential dangers of administering live viral vaccines to individuals with compromised immune systems, even if they appear to be in remission.
Continuous viral activity can be a marker for persistent, unrecognized underlying disease.

Implications:

This case underscores the critical need for careful screening and risk assessment before live viral vaccination in immunocompromised individuals.
It suggests that persistent viral infections warrant further investigation for underlying immune deficiencies or disease recurrence.

Related Experiment Videos